Wang Xutong, Gao Zeyu, Liu Yu, Wang Peiying, Fang Xiaodong, Sun Meng, Ma Kejing, Wang Bing, Han Weina
Department of Medicinal Chemistry and Natural Medicine Chemistry, College of Pharmacy, HarBin Medical University, Harbin, PR China.
Center for Pharmacy Informatics, College of Pharmacy, HarBin Medical University, Harbin, PR China.
Bioorg Med Chem Lett. 2025 Apr 1;118:130083. doi: 10.1016/j.bmcl.2024.130083. Epub 2024 Dec 24.
The telomeric G-quadruplex (G4) along with the telomerase catalytic subunit hTERT are crucial in the extension of telomeres. Tumor cells can establish replicative immortality by activating the telomere-maintenance mechanism (TMM).Small molecule ligands can limit cancer telomere lengthening by by targeting at G4 and hTERT. The 144 structures were designed by summarising the common structure-activity relationship of G4 stabilisers and hTERT inhibitors.Molecular docking and mtQSAR activity prediction experiments finally identified a16 and a35 as the optimal structures. Subsequently their derivative compounds b1-b6 were synthesised,with b4 exhibiting the most pronounced inhibitory effect on tumour cells. The ability of b4 to distinguish single-stranded DNA, double-stranded DNA and telomere G4 was verified by fluorescence experiment, and the stable combination of b4 and hTERT was verified by molecular dynamics simulation. This suggests that the structural design of targeting G4 and hTERT is reasonable and has anti-tumor potential.
端粒G-四链体(G4)与端粒酶催化亚基hTERT在端粒延长过程中至关重要。肿瘤细胞可通过激活端粒维持机制(TMM)实现复制永生。小分子配体可通过靶向G4和hTERT来限制癌症端粒延长。通过总结G4稳定剂和hTERT抑制剂的共同构效关系设计了144种结构。分子对接和mtQSAR活性预测实验最终确定a16和a35为最佳结构。随后合成了它们的衍生物b1-b6,其中b4对肿瘤细胞表现出最显著的抑制作用。通过荧光实验验证了b4区分单链DNA、双链DNA和端粒G4的能力,并通过分子动力学模拟验证了b4与hTERT的稳定结合。这表明靶向G4和hTERT的结构设计是合理的,具有抗肿瘤潜力。